市场调查报告书
商品编码
1182092
家禽保健全球市场规模研究和预测,按产品类型、试验类型和地区分析,2022-2029Global Poultry Healthcare Market Size study & Forecast, by Product Type, Test Type and Regional Analysis, 2022-2029 |
家禽保健是指家畜和其他家禽的治疗。
将各种动物衍生产品推向市场。 由于人畜共患疾病发病率上升以及对家禽衍生食品和杂货的需求增加等因素,家禽保健市场正在扩大。 此外,由于私营公司的战略举措和医疗保健行业的增长,预计市场将扩大。 该市场由 Elanco、Zoetic Inc、Merck &Co Inc、Hester Biosciences Limited 等公司主导。
疾病的治疗需求随着病例数量的增加而显着增加,预计这将在预测期内推动市场增长。 例如,根据加拿大政府公布的2022年数据,截至2022年6月,艾伯塔省预计将有963,889隻鸟类感染禽流感,其次是安大略省560,536只,魁北克省300,835只。 此外,根据 2021 年 11 月发表的论文“印度哈里亚纳邦工业家禽和庭院家禽中新城疫病毒的流行情况”,从 2018 年 3 月到 2020 年 3 月进行了分层调查。 使用 M 基因 rRT-PCR 显示,商品肉鸡和蛋鸡的新城疫病毒 (NDV) 检测均呈阳性。 根据同一来源,患有轻度呼吸道疾病的鸡群新城疫病毒的流行率较高(15.7%),其次是健康鸡群(9.1%)和病鸡群(3.0%)。 然而,假药的使用、市场上缺乏兽医和熟练的农场工人短缺会阻碍市场增长。
全球家禽保健市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 北美在收入方面占据主导地位,对鸡肉衍生食品的需求不断增长。 根据 Nass.usda.gov 的数据,2020 年肉鸡总产量为 217 亿美元,比 2019 年下降 23%。 2020年肉鸡爆发总量为92.2亿隻,较2019年有所增加。 2020年肉鸡鲜重594亿斤,比2019年增长2%。 由于上升,预计亚太地区在预测期内将显着增长。
这项研究的目的是定义近年来各个细分市场和国家/地区的市场规模,并预测它们在未来几年的价值。 该报告旨在包括被调查国家工业的定性和定量方面。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。 此外,它还包含供利益相关者投资的微观市场潜在机会,以及对主要参与者的竞争格局和产品供应的深入分析。
Global Poultry Healthcare Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. Poultry Healthcare refers to the method of treating the animals and other poultry animals. For deriving various animal-based products in the market. The Poultry Healthcare market is expanding because of factors such as rising Occurrence of Zoonotic Diseases and rising demand for Poultry-derived Food and food Products. The market is expected to rise owing to strategic initiatives by the private players in the market and rising healthcare industry. The market is dominated by Elanco, Zoetic Inc, Merck & Co Inc, Hester Biosciences Limited and others.
The need to treat the disorders has increased significantly as well as the number of cases, which is anticipated to fuel market growth during the forecast period. For instance, the 2022 figures released by the Government of Canada show that as of June 2022, it was anticipated that 963,889 birds in Alberta will be affected by avian influenza in 2022, followed by 560,536 birds in Ontario and 300,835 birds in Quebec. Further, according to a November 2021 paper titled "Prevalence of Newcastle Disease Virus in Industrial and Backyard Poultry in Haryana, India," a stratified research study was carried out from March 2018 to March 2020. Using the M gene rRT-PCR, it was revealed that both commercial broilers and layers tested positively for Newcastle disease virus (NDV). According to the same source, flocks with mild respiratory problems showed a higher prevalence of Newcastle disease virus (15.7%), followed by healthy (9.1%) and sick (3.0%) flocks. However, use of counterfeit medicines, lack of veterinarians in the market and shortage of skilled farm workers may halt market growth.
The key regions considered for the Global Poultry Healthcare Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, rising demand for poultry-derived food products. According to Nass.usda.gov, Broilers produced in 2020 were valued at USD 21.7 billion, a 23% decrease from 2019. In 2020, 9.22 billion broilers were generated in total, an increase from 2019. In 2020, 59.4 billion pounds of live weight broilers were generated, an increase of 2% from 2019. Asia Pacific is expected to grow significantly during the forecast period, owing to rising
Major market players included in this report are:
Indovax
Thermo Fisher Scientific Inc.
Boehringer Ingelheim GmbH
Ceva Sante Animale
Merck & Co Inc
IDEXX Laboratories, Inc.
Megacor Diagnostik GmbH
Elanco
Zoetis Inc.
Hester Biosciences Limited
Recent Developments in the Market:
Global Poultry Healthcare Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product Type, Test Type and Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product type:
Vaccines
Parasiticides
Anti-Infectives
Medical Feed Additives
Others
By Test Type:
Elisa Test
PCR Test
Molecular Diagnostic Test
Other Test Types
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable